Aldeyra Therapeutics was hoping the third time would be the charm for its dry eye drug this St. Patrick’s Day. No such luck. The FDA
The biopharma industry is looking for creative ways to cushion the effect of the Trump administration’s “most favored nation” deals on US pricing. Two lawyers
Today we’re announcing two exciting editorial hires at Endpoints News: Karen Weintraub + Kevin Miller. Karen Weintraub is our new deputy editor and will help
Epic last week scored a win in a lawsuit that revolves around who has a right to patient health data. On Friday, the electronic health
Plus, news about Genentech, Mestag and BioVie: 📊 Pfizer says next-gen breast cancer drug succeeds in Phase 2: The company is developing a CDK4 inhibitor
To help with new pilot models aimed at lowering drug costs across Medicaid and Medicare, CMS’ innovation center is ramping up staff.
“We are on track to more than double the size of our team …
Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844